Online GLP-1 Programs in South Carolina

Insurance

Does South Carolina Medicaid cover GLP-1s?

South Carolina Healthy Connections (Medicaid) added coverage of GLP-1s for weight loss on November 1, 2024, then eliminated it effective January 1, 2026, making it one of only four states (with California, New Hampshire, and Pennsylvania) to roll back the benefit (KFF, 2026; SC Daily Gazette, 2025). The state projected the benefit would cost about $10 million a year for roughly 1,300 qualifying beneficiaries. Coverage for type 2 diabetes continues, as federal law requires.

Online Access

Getting a GLP-1 online in South Carolina

GLP-1s are not controlled substances, so South Carolina allows them to be prescribed via telehealth once a valid physician-patient relationship is established. State law bars prescribing based solely on an online questionnaire (SC Code §40-47-113), so a real clinical evaluation is required. The prescriber must hold a South Carolina license.

Compounding

Compounded semaglutide & tirzepatide in South Carolina

Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). South Carolina adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.

Demand

Where GLP-1 demand is highest in South Carolina

About 35% of South Carolina adults have obesity and roughly 14% have diagnosed diabetes (CDC BRFSS via America's Health Rankings, 2024). Demand centers on the Charleston, Columbia, and Greenville areas. With Medicaid having added then dropped weight-loss coverage within about 14 months, and the state not having expanded Medicaid, most residents now rely on cash-pay or telehealth.

Questions

South Carolina GLP-1 FAQ

Compound Guides

The GLP-1s behind these programs

Sources

How we sourced this page

Coverage, prevalence, and policy figures are drawn from primary and authoritative sources, last reviewed June 2026.